- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- May 2026
- 350 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- June 2026
- 383 Pages
Global
From €2245EUR$2,500USD£1,918GBP
- Report
- April 2026
- 135 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- April 2026
- 142 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- July 2026
- 160 Pages
Global
From €3727EUR$4,150USD£3,184GBP
- Report
- October 2025
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- October 2025
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- January 2026
- 160 Pages
Global
From €4486EUR$4,995USD£3,832GBP
- Report
- July 2026
- 160 Pages
Global
From €3727EUR$4,150USD£3,184GBP
- Report
- January 2026
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- July 2026
- 135 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- September 2025
- 135 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- April 2026
- 150 Pages
United States
From €5344EUR$5,950USD£4,565GBP
- Report
- December 2025
- 150 Pages
United States
From €4356EUR$4,850USD£3,721GBP
- Report
- October 2025
- 99 Pages
Middle East
From €4042EUR$4,500USD£3,453GBP
- Report
- August 2024
- 381 Pages
Global
From €4310EUR$4,799USD£3,682GBP
- Report
- November 2024
- 239 Pages
Global
From €3750EUR$4,175USD£3,203GBP

Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more